Loading clinical trials...
Loading clinical trials...
Insulin resistance increases the risk of type 2 diabetes and cardiovascular disease, with gut dysbiosis emerging as a contributing factor. Metabolic endotoxemia, characterized by elevated serum lipopo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Jordan
NCT07415720 · Diabete Type 2, Obesity & Overweight, and more
NCT07550023 · Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition, and more
NCT05543083 · Insulin Resistance, Depression, and more
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Aseel nutrition center
Amman
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions